CEUTA HEALTHCARE LIMITED

PaymentCheck Score 2023
41Poor
16.5vs last year
#4660 in UK
#769 in South East

Company Information

Company Number
02974951
Registered Address
3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
Status
Active
Employee Count
134
Turnover
£61,177,000
EBITDA
£4,460,000

Additional Details

Company Type
Private limited Company
Incorporated On
6 October 1994
Nature of Business
86900 - Other human health activities
Industries
Healthcare And Wellbeing
Region
South East

Time to Pay

Average Time to Pay
38 days
Shortest Period:30 days
Longest Period:0 days
Max Contractual:75 days

Payment Timeline

Within 30 Days
21%
31-60 Days
55%
After 60 Days
24%
Not Paid Within Terms77%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Company Review

Trend Analysis

The data reveals CEUTA HEALTHCARE LIMITED consistently pays beyond standard 30-day terms, with an average payment time of 38 days. Only 21% of payments are completed within 30 days, indicating a clear trend towards extended payment cycles. The predominant payment window is 31-60 days (55%), suggesting a generally predictable, albeit delayed, payment pattern.

Volatility Analysis

While 77% of payments are categorized as late, the significant concentration (55%) within the 31-60 day period provides some degree of predictability for suppliers regarding extended payment timelines. However, the 24% of payments exceeding 60 days introduces a notable risk of extended and less predictable delays. This long tail creates an element of uncertainty that could negatively impact a supplier's cash flow planning.

Summary Analysis

Suppliers should anticipate an average payment period of 38 days, with a high likelihood of payments extending beyond 30 days, before engaging with CEUTA HEALTHCARE LIMITED. Key decision factors include the supplier's ability to manage extended payment terms and potential cash flow strain from payments exceeding 60 days. It is recommended to implement risk mitigation strategies such as adjusting pricing, negotiating favorable upfront payment terms, or exploring invoice financing to manage the prevalent payment delays.

Performance Reports History

Reporting Period Filed: 2023-11-20
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Apr 2023 - 30 Apr 202320 Nov 20233821%55%24%77%
01 Oct 2022 - 31 Mar 202305 Jun 20233952%38%10%61%
01 Apr 2022 - 30 Sept 202201 Nov 20224147%41%12%67%
01 Oct 2021 - 31 Mar 202229 Apr 20223949%40%11%55%
01 Apr 2021 - 30 Sept 202129 Oct 20213951%38%11%50%
01 Oct 2020 - 31 Mar 202104 May 20215352%35%13%63%
01 Apr 2020 - 30 Sept 202003 Nov 20204542%42%16%78%
01 Oct 2019 - 31 Mar 202005 May 20204657%31%12%76%
01 Apr 2019 - 30 Sept 201931 Oct 20194247%41%11%67%
01 Oct 2018 - 30 Apr 201902 May 20194654%31%15%75%
01 Apr 2018 - 30 Sept 201829 Oct 20183856%32%11%61%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

It is Company policy to agree appropriate terms of payment with each supplier, and to pay invoices in line with those terms subject to the timely submission of satisfactory invoices. The majority of our suppliers are on 30 day payment terms with the exception of import duty which is paid immediately.

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

75

Dispute Resolution Process

The Company is committed to dealing with its suppliers in a fair, honest and professional manner. We seek to resolve queries as quickly as possible to both parties satisfaction prior to payment being made. The invoice approver will reject an invoice they dispute and will advise the Purchase Ledger department why and the steps needed to resolve the issue. The approver will then contact their supplier to discuss the issue for resolution. Purchase Ledger will follow up outstanding queries each week and escalate to the approvers’ manager if a satisfactory resolution has not been found. When the invoice becomes aged this is escalated to the Finance Manager and then Finance Director for further action.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

CEUTA HEALTHCARE LIMITED operates as a private limited company within the healthcare sector. Its name clearly indicates its focus on healthcare-related activities and commercial operations.

This active private limited company was incorporated on 6 October 1994, identified by company number 02974951. Its registered office is located at 3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH, placing its primary operational base within the South East of England.

Companies operating within the UK healthcare sector typically provide a diverse range of services and products. These commonly include the provision of medical devices, pharmaceuticals, healthcare technology solutions, or direct healthcare services such as clinical support and consultancy.

Financial Metrics

Cash
£6,600,000
Net Worth
£8,000,000
Total Current Assets
£46,500,000
Total Current Liabilities
£38,500,000

Company Location